Systematic Characterization of Recurrent Genomic Alterations in Cyclin-Dependent Kinases Reveals Potential Therapeutic Strategies for Cancer Treatment

Summary: Recurrent copy-number alterations, mutations, and transcript fusions of the genes encoding CDKs/cyclins are characterized in >10,000 tumors. Genomic alterations of CDKs/cyclins are dominantly driven by copy number aberrations. In contrast to cell-cycle-related CDKs/cyclins, which are glo...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Weiwei Shan, Jiao Yuan, Zhongyi Hu, Junjie Jiang, Yueying Wang, Nicki Loo, Lingling Fan, Zhaoqing Tang, Tianli Zhang, Mu Xu, Yutian Pan, Jiaqi Lu, Meixiao Long, Janos L. Tanyi, Kathleen T. Montone, Yi Fan, Xiaowen Hu, Youyou Zhang, Lin Zhang
Формат: Artigo
Язык:Inglês
Опубликовано: Elsevier 2020-07-01
Серии:Cell Reports
Предметы:
genomic alteration
cyclin-dependent kinase
cancer
CDK7 inhibitor
PARP inhibitor
combination therapy
Online-ссылка:http://www.sciencedirect.com/science/article/pii/S2211124720308652
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы